glp-1 shortage us North Carolina among the states with high rates of Ozempic prescriptions Ozempic Statistics: GLP-1 Weight Loss

In a 52-week phase II trial involving patients with MASH and advanced fibrosis, tirzepatide demonstrated dose-dependent benefits in resolving MASH, with the highest dose achieving a resolution rate of 62%

Microvascular effects of glucagon-like peptide-1 receptor agonists in type 2 diabetes: a meta-analysis of randomized controlled trials

Insurance companies typically do not cover OFF LABEL prescribing of FDA approved for type 2 diabetes for weight loss without a type 2 diabetes diagnosis

GLP-1 medications are designed to be injected into fatty tissue just beneath the skin

Small-molecule albumin ligand modification to enhance the anti-diabetic ability of GLP-1 derivatives